Publications by authors named "J Boehmer"
Article Synopsis
- * An 18-month pilot intervention was conducted at eight VA medical centers, with CWOs overseeing implementation and monitoring progress through surveys and qualitative interviews.
- * Results indicated that not formally hiring CWOs limited their effectiveness, but some positive changes in workplace culture and readiness for change were noted, emphasizing the need for a structured CWO role and comprehensive interventions to better support workforce well-being.
Background: There is an unmet need for early detection of heart failure decompensation, allowing patients to be managed remotely and avoid hospitalization.
Objectives: The purpose of this study was to compare a strategy utilizing data from a wearable HF sensor for management following a HF hospitalization to usual care.
Methods: Eligible subjects were discharged from the hospital within the previous 10 days and had a HF event in the previous 6 months.
Aims: Interatrial shunts are under evaluation as a treatment for heart failure (HF); however, their in vivo flow performance has not been quantitatively studied. We aimed to investigate the fluid dynamics properties of the 0.51 cm orifice diameter Ventura shunt and assess its lumen integrity with serial transesophageal echocardiography (TEE).
View Article and Find Full Text PDFBackground: Right ventricular (RV) systolic dysfunction has been identified as a prognostic marker for adverse clinical events in patients presenting with acute pulmonary embolism (PE). However, challenges exist in identifying RV dysfunction using conventional echocardiography techniques. Strain echocardiography is an evolving imaging modality which measures myocardial deformation and can be used as an objective index of RV systolic function.
View Article and Find Full Text PDFAims: Heart failure (HF) outcomes remain poor despite optimal guideline-directed medical therapy (GDMT). We assessed safety, effectiveness, and transthoracic echocardiographic (TTE) outcomes during the 12 months after Ventura shunt implantation in the RELIEVE-HF open-label roll-in cohort.
Methods And Results: Eligibility required symptomatic HF despite optimal GDMT with ≥1 HF hospitalization in the prior year or elevated natriuretic peptides.